×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Morphosys says takeover by Novartis on course after report of drug safety concern
Reuters
Morphosys said its takeover by Novartis is still expected to close in the first half of this year, after a news report on a possible drug...
5 hours ago
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition
STAT
MorphoSys is dealing with an emerging safety issue related to pelabresib, the experimental treatment for myelofibrosis, STAT has learned.
20 hours ago
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT
BioSpace
Citing anonymous sources involved in a Phase III trial, STAT News reported Sunday that MorphoSys' pelabresib may worsen the risk of...
2 hours ago
Morphosys says Novartis takeover progressing as planned for H1 2024
SRN News
BERLIN (Reuters) – Morphosys said its takeover by Novartis was still expected to be closed in the first half of this year, in a statement...
4 hours ago
Deciphex partners with Novartis for AI drug research
Silicon Republic
Irish pathology company Deciphex has announced a partnership with Swiss pharma giant Novartis to develop AI tools for drug discovery and development.
5 hours ago
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia
Fierce Pharma
Novartis is mitigating a potential threat from the BIOSECURE Act. A Neurocrine drug from Takeda posted a trial win. Enhertu nears a HER2-low...
3 days ago
Novartis, Danaher rise; Nucor, Cadence Design Systems fall, Tuesday, 4/23/2024
ABC News - Breaking News, Latest News and Videos
Stocks that traded heavily or had substantial price changes on Tuesday: Novartis, Danaher rise; Nucor, Cadence Design Systems fall.
5 days ago
Drugmaker Novartis climbs after guidance rise on sales of blockbuster drugs
CNBC
Shares of Swiss drugmaker Novartis climbed as much as 4.8% in early deals Tuesday after it raised its full-year guidance following...
6 days ago
Novartis Ag (NVS) Q1 2024 Earnings Call Transcript
The Motley Fool
Novartis Ag (NVS -1.64%) Q1 2024 Earnings Call Apr 23, 2024, 8:00 a.m. ET. Contents: Prepared Remarks; Questions and Answers...
5 days ago
Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript
Yahoo Finance
Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript April 23, 2024 Novartis AG isn't one of the 30 most popular stocks among hedge funds...
5 days ago